Fig. 2From: Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility studyLoge10MWT at baseline and 6 months, with line of equality. Different shapes represent patients from different countries. 10MWT = 10 min-walking time; sec = secondsBack to article page